Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q9)Dec 31, 2024 | (Q6)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q9)Dec 31, 2023 | (Q6)Sep 30, 2023 | (Q1)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 42.00%1.12B | 98.76%622.1M | 8.45%1.48B | 23.31%1.3B | 34.22%786.18M | 37.20%313M | -36.07%1.37B | -47.31%1.06B | -58.18%585.75M | -66.96%228.13M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 0.60%-54.82M | -5.00%-27.73M | 25.77%-109.96M | 29.85%-82.44M | 33.15%-55.15M | 34.27%-26.41M | -4.56%-148.13M | -19.42%-117.52M | -46.63%-82.5M | -115.12%-40.17M |
| Dividend (income)- adjustment | -54.23%-3.02M | -64.69%-1.14M | -176.65%-8.11M | -299.24%-5.25M | -163.09%-1.96M | -4.70%-691K | -5.43%-2.93M | 66.90%-1.32M | 55.04%-745K | 45.72%-660K |
| Attributable subsidiary (profit) loss | -37.96%9.01M | -48.44%3.87M | -22.14%19.98M | 28.62%19.92M | 11.59%14.53M | 59.79%7.5M | 52.74%25.66M | 41.81%15.49M | 50.95%13.02M | -7.51%4.7M |
| Impairment and provisions: | 196.80%128.27M | -55.52%20.86M | 162.51%123.14M | --90.73M | --43.22M | --46.89M | 5,141.23%46.91M | ---- | ---- | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | --10.47M | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | 222.68%79.4M | 80.07%-3.78M | ---- | ---- | ---64.72M | ---18.95M | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | -38.08%23.59M | -6.50%16.26M | ---- | ---- | --38.09M | --17.39M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | -63.80%25.28M | -82.71%8.38M | 237.97%123.14M | --90.73M | --69.85M | --48.45M | 3,970.95%36.44M | ---- | ---- | ---- |
| Revaluation surplus: | -753.84%-96.13M | -1,020.34%-171.01M | 113.18%39.18M | 12.84%-83.12M | 88.94%-11.26M | 78.36%-15.26M | -20.66%-297.3M | 38.41%-95.37M | 23.35%-101.83M | 39.59%-70.54M |
| -Derivative financial instruments fair value (increase) | ---4.6M | ---152.36M | --118.28M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other fair value changes | -712.98%-91.53M | -22.16%-18.65M | 73.40%-79.09M | 12.84%-83.12M | 88.94%-11.26M | 78.36%-15.26M | -20.66%-297.3M | 38.41%-95.37M | 23.35%-101.83M | 39.59%-70.54M |
| Asset sale loss (gain): | 110.94%2.57M | 99.54%-107K | -189.74%-15.54M | -294.54%-22.24M | -313.39%-23.47M | -761.39%-23.29M | 167.19%17.32M | 808.82%11.43M | 498.97%11M | 1,194.85%3.52M |
| -Loss (gain) from sale of subsidiary company | 96.35%-826K | 96.79%-727K | -188,458.33%-22.63M | -188,458.33%-22.63M | ---22.63M | ---22.63M | 99.07%-12K | 98.98%-12K | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 352.15%2.88M | 158.92%568K | 3.36%3.6M | 98.42%-38K | -202.15%-1.14M | -69.72%-964K | -43.84%3.48M | -324.12%-2.41M | 141.77%1.12M | -323.62%-568K |
| -Loss (gain) from selling other assets | 71.43%516K | -82.49%52K | -74.81%3.49M | -96.95%423K | -96.95%301K | -92.74%297K | 776.71%13.85M | 915.54%13.85M | 624.34%9.88M | 51,025.00%4.09M |
| Depreciation and amortization: | 0.21%703.03M | -0.23%345.57M | 0.42%1.42B | 3.18%1.08B | 2.07%701.54M | 1.99%346.36M | 4.47%1.41B | 2.94%1.04B | 3.37%687.33M | 2.47%339.6M |
| -Amortization of intangible assets | -5.60%399.96M | -7.50%194.36M | 1.98%849.31M | 5.09%651.95M | 4.95%423.68M | 6.89%210.11M | 1.07%832.78M | -1.57%620.39M | -2.72%403.69M | -4.16%196.58M |
| Financial expense | -10.60%357.15M | -6.89%186.56M | 1.37%773.27M | 5.31%592.12M | 3.02%399.51M | 1.49%200.38M | 15.98%762.81M | 22.22%562.26M | 40.90%387.8M | 96.77%197.43M |
| Special items | 16.73%161.95M | 29.40%80.06M | 4.56%290.25M | -7.53%211.61M | -6.94%138.74M | -9.86%61.87M | -16.89%277.57M | -5.23%228.85M | -6.12%149.09M | -7.95%68.63M |
| Operating profit before the change of operating capital | 16.69%2.32B | 16.34%1.06B | 15.94%4.01B | 14.68%3.1B | 20.80%1.99B | 24.60%910.34M | -15.88%3.46B | -22.19%2.71B | -28.90%1.65B | -31.43%730.63M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 69.05%-734.35M | 29.68%-749.95M | -276.19%-1.36B | -1,956.16%-2.49B | -1,372.04%-2.37B | -335.40%-1.07B | -119.23%-360.69M | -82.48%133.88M | 248.79%186.54M | 179.90%453.05M |
| Accounts receivable (increase)decrease | -51.54%-3.89B | -154.65%-1.05B | -1,446.20%-2.95B | -93.55%-2.63B | -126.87%-2.56B | -197.89%-412.18M | -104.05%-190.93M | -140.24%-1.36B | -135.95%-1.13B | 6.44%421.06M |
| Accounts payable increase (decrease) | 4.78%5.66B | 32.69%2.29B | 538.82%2.56B | 553.59%5.21B | 469.80%5.41B | 358.69%1.73B | 105.88%401.08M | 117.94%797.05M | 135.46%948.77M | -74.28%-667.74M |
| Special items for working capital changes | 92.60%-10.2M | 121.31%14.37M | -19.30%47.59M | -286.21%-252.37M | -187.28%-137.86M | -156.16%-67.46M | 20.13%58.97M | 172.38%135.53M | -32.11%157.96M | 40.12%120.12M |
| Cash from business operations | 44.57%3.36B | 43.45%1.57B | -31.35%2.31B | 22.00%2.94B | 28.20%2.32B | 3.26%1.09B | -14.38%3.37B | -25.22%2.41B | -37.44%1.81B | 77.17%1.06B |
| Other taxs | -73.82%-278.07M | -69.03%-180.79M | 20.60%-487.43M | 36.04%-253.6M | 51.50%-159.97M | 50.59%-106.96M | -16.24%-613.9M | -50.83%-396.51M | -100.10%-329.85M | -126.29%-216.45M |
| Interest paid - operating | 17.40%-317.74M | 14.06%-166.09M | 2.47%-725.69M | -3.51%-567.51M | -1.66%-384.65M | -1.23%-193.26M | -22.95%-744.05M | -34.94%-548.27M | -52.44%-378.37M | -86.60%-190.91M |
| Net cash from operations | 55.34%2.76B | 54.04%1.22B | -45.31%1.1B | 44.59%2.12B | 61.12%1.78B | 21.80%791.39M | -28.21%2.01B | -42.60%1.47B | -55.56%1.1B | 62.96%649.76M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -0.60%54.82M | 5.00%27.73M | -23.67%109.96M | -26.94%82.44M | -29.69%55.15M | -34.27%26.41M | 15.51%144.07M | 38.51%112.84M | 58.10%78.44M | 115.12%40.17M |
| Dividend received - investment | 54.23%3.02M | 64.69%1.14M | 176.65%8.11M | 299.24%5.25M | 163.09%1.96M | 4.70%691K | 5.43%2.93M | -66.90%1.32M | -55.04%745K | -45.72%660K |
| Loan receivable (increase) decrease | -196.72%-5.4M | 85.81%-881K | -85.70%3.41M | -97.55%636K | -81.07%5.58M | -131.67%-6.21M | 315.57%23.83M | --25.95M | --29.47M | --19.6M |
| Decrease in deposits (increase) | -226.97%-6.76M | 76.95%6.24M | -511.06%-23.05M | -1,668.82%-70.99M | -42.06%5.32M | 28.77%3.53M | -73.73%5.61M | -85.28%4.53M | -71.42%9.18M | -92.16%2.74M |
| Sale of fixed assets | 96.21%24.66M | -23.39%4.47M | 38.94%38.92M | 4.81%26.54M | -34.27%12.57M | -64.76%5.84M | -14.28%28.01M | 35.91%25.32M | 17.39%19.12M | 41.18%16.56M |
| Purchase of fixed assets | -42.98%-239.56M | -12.98%-91.85M | -28.31%-352.98M | -46.25%-258.3M | -29.79%-167.55M | -31.69%-81.3M | 35.78%-275.1M | 39.41%-176.62M | 33.40%-129.09M | 33.68%-61.73M |
| Purchase of intangible assets | -65.05%-401.97M | -93.92%-290.85M | 12.85%-484.67M | 17.53%-418.15M | 21.50%-243.55M | 4.24%-149.99M | -20.61%-556.12M | -38.60%-507.02M | -28.71%-310.24M | 2.11%-156.62M |
| Sale of subsidiaries | 129.04%4.14M | 107.37%1.05M | -4,659.74%-14.27M | ---14.27M | ---14.27M | ---14.27M | --313K | ---- | ---- | ---- |
| Acquisition of subsidiaries | 34.00%-4.25M | ---425K | 27.96%-8.92M | 32.12%-8.37M | 47.78%-6.44M | ---- | 87.99%-12.38M | 87.88%-12.32M | 85.29%-12.32M | ---- |
| Recovery of cash from investments | 219.42%104.45M | 354.24%35.93M | 11.04%138.04M | -3.04%112.72M | -67.41%32.7M | -91.25%7.91M | -45.88%124.31M | -23.40%116.26M | -8.28%100.32M | 183.99%90.4M |
| Cash on investment | -51.35%-312.04M | -0.86%-113.32M | 38.77%-470.83M | 49.08%-317.44M | 54.62%-206.17M | 25.99%-112.36M | 41.99%-768.93M | 44.90%-623.37M | 48.61%-454.36M | 34.79%-151.81M |
| Net cash from investment operations | -48.44%-778.88M | -31.59%-420.77M | 17.70%-1.06B | 16.76%-859.93M | 21.54%-524.7M | -59.85%-319.75M | 32.98%-1.28B | 35.47%-1.03B | 43.98%-668.74M | 48.42%-200.03M |
| Net cash before financing | 58.23%1.98B | 69.26%798.31M | -94.01%43.55M | 190.45%1.26B | 188.26%1.25B | 4.87%471.64M | -17.92%727.54M | -54.54%434.6M | -66.27%434.81M | 4,007.52%449.73M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 1.39%6.7B | 37.45%4.33B | 44.28%17.01B | 102.82%13.65B | 162.68%6.61B | 122.24%3.15B | 7.40%11.79B | -31.12%6.73B | -65.74%2.52B | -59.87%1.42B |
| Refund | -1.32%-6.73B | -37.72%-4.34B | -44.43%-17.04B | -102.22%-13.63B | -166.16%-6.64B | -123.85%-3.15B | -7.46%-11.8B | 30.88%-6.74B | 65.95%-2.49B | 59.85%-1.41B |
| Issuing shares | ---- | ---- | --2.21B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Dividends paid - financing | -1.11%-496.96M | 51.05%-1.29M | -8.11%-680.15M | -3.51%-645.16M | -3.56%-491.5M | 74.61%-2.63M | -1.47%-629.14M | -2.35%-623.31M | -3.45%-474.62M | -1,193.50%-10.35M |
| Absorb investment income | -70.22%23.16M | 3,029.87%14.46M | -18.52%91.78M | -27.91%78.02M | 1.68%77.76M | -83.26%462K | 349.63%112.65M | 411.36%108.22M | 580.59%76.47M | -75.44%2.76M |
| Issuance expenses and redemption of securities expenses | ---965M | ---965M | 84.71%-20.19M | ---- | ---- | ---- | 90.36%-132.08M | 84.22%-132.08M | 93.45%-51.28M | ---- |
| Other items of the financing business | 23.05%-128.81M | -874.52%-97.31M | 51.48%-265.25M | 69.38%-130.84M | 54.56%-167.4M | 96.02%-9.99M | -166.20%-546.68M | -598.33%-427.3M | -1,292.05%-368.39M | -2,182.94%-250.78M |
| Net cash from financing operations | -144.64%-1.65B | -2,202.89%-1.09B | 189.06%1.19B | 34.55%-773.39M | 21.44%-674.26M | 83.34%-47.21M | -222.91%-1.34B | -474.70%-1.18B | -239.14%-858.25M | -3,235.51%-283.39M |
| Effect of rate | 25.93%50.31M | 189.14%65.2M | 20.26%-65.14M | -209.74%-114.27M | 144.56%39.95M | -18.68%-73.14M | 46.54%-81.69M | 79.81%-36.89M | 66.66%-89.66M | 57.39%-61.63M |
| Net Cash | -42.38%333.69M | -168.06%-288.88M | 302.68%1.23B | 165.44%488.89M | 236.77%579.13M | 155.15%424.43M | -228.77%-608.56M | -158.76%-747.03M | -122.22%-423.44M | 6,681.37%166.35M |
| Begining period cash | 32.82%4.73B | 32.82%4.73B | -16.24%3.56B | -16.24%3.56B | -16.24%3.56B | -16.24%3.56B | 8.14%4.25B | 8.14%4.25B | 8.14%4.25B | 8.14%4.25B |
| Cash at the end | 22.33%5.11B | 15.17%4.5B | 32.82%4.73B | 13.51%3.93B | 11.83%4.18B | -10.19%3.91B | -16.24%3.56B | -30.94%3.47B | -32.88%3.74B | 14.96%4.35B |
| Cash balance analysis | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | -- | PwC Accounting Firm | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.